Sustainability As Reputation Infrastructure

Regulations in the Philippines now mandate structured sustainability disclosures, reinforcing the shift from voluntary initiatives to audited institutional requirements.

How Chef Tatung Learned To Let Simpol Grow Beyond Him

Behind Simpol’s familiar tone is a deliberate process, where discipline and shared understanding help transform simple content into something that resonates across platforms and audiences.

Prifood, COREnergy Team Up To Optimize Energy Use Under RAP

Prifood partners with COREnergy to optimize energy use and strengthen operational efficiency across its facilities.

9Lives And Vision Express Introduce A New Eyewear Collection With A Modern 90s Edge

The new 9Lives eyewear collection with Vision Express revisits 90s fashion through bold frames and modern design, blending nostalgia with a refined and contemporary edge.

Global Coronavirus Cases Surpass 40M

The number of the COVID-19 cases in the world has surpassed 40 million on Monday.

Global Coronavirus Cases Surpass 40M

72
72

How do you feel about this story?

Like
Love
Haha
Wow
Sad
Angry

The number of the coronavirus disease 2019 (Covid-19) cases in the world has surpassed 40 million early Monday, according to Johns Hopkins University data.

More than 1.11 million people have lost their lives around the world from Covid-19 so far.

The US still leads the world in the number of Covid-19 cases with over 8.15 million, while deaths are at almost 220,000.

In India, more than 7.55 million people contracted the virus with a death toll of over 114,600. Brazil has more than 5.22 million cases and a death toll exceeding 153,600.

China, the birthplace of Covid-19, has close to 91,000 cases with 4,739 deaths.

The UK’s Scientific Advisory Group for Emergencies said Sunday more than one coronavirus vaccine will be available at the beginning of 2021.

American pharmaceutical firm Pfizer said Friday it may know the effectiveness of its vaccine by the end of October, and it is planning to submit safety data on the final dose of the vaccine to the US Food and Drug Administration in the third week of November.

A vaccine candidate developed by the Beijing Institute of Biological Products, affiliated to the state-owned China National Pharmaceutical Group (Sinopharm), elicited antibody response in recipients, according to a study published Thursday in the Lancet Infectious Diseases journal.

Meanwhile, Russian President Vladimir Putin said Wednesday that a second coronavirus vaccine, EpiVakKorona, has been granted regulatory approval.

There are more than 170 vaccines around the world that are candidates for Covid-19 and tracked by the World Health Organization, but none has been approved for general use yet. (PNA)